RESUMEN
BACKGROUND: Psychological therapies can be effective in reducing symptoms of depression and anxiety in people living with dementia (PLWD). However, factors associated with better therapy outcomes in PLWD are currently unknown. AIMS: To investigate whether dementia-specific and non-dementia-specific factors are associated with therapy outcomes in PLWD. METHOD: National linked healthcare records were used to identify 1522 PLWD who attended psychological therapy services across England. Associations between various factors and therapy outcomes were explored. RESULTS: People with frontotemporal dementia were more likely to experience reliable deterioration in depression/anxiety symptoms compared with people with vascular dementia (odds ratio 2.98, 95% CI 1.08-8.22; P = 0.03) or Alzheimer's disease (odds ratio 2.95, 95% CI 1.15-7.55; P = 0.03). Greater depression severity (reliable recovery: odds ratio 0.95, 95% CI 0.92-0.98, P < 0.001; reliable deterioration: odds ratio 1.73, 95% CI 1.04-2.90, P = 0.04), lower work and social functioning (recovery: odds ratio 0.98, 95% CI 0.96-0.99, P = 0.002), psychotropic medication use (recovery: odds ratio 0.67, 95% CI 0.51-0.90, P = 0.01), being of working age (recovery: odds ratio 2.03, 95% CI 1.10-3.73, P = 0.02) and fewer therapy sessions (recovery: odds ratio 1.12, 95% CI 1.09-1.16, P < 0.001) were associated with worse therapy outcomes in PLWD. CONCLUSIONS: Dementia type was generally not associated with outcomes, whereas clinical factors were consistent with those identified for the general population. Additional support and adaptations may be required to improve therapy outcomes in PLWD, particularly in those who are younger and have more severe depression.
Asunto(s)
Demencia , Atención Primaria de Salud , Humanos , Masculino , Femenino , Inglaterra , Anciano , Atención Primaria de Salud/estadística & datos numéricos , Demencia/terapia , Persona de Mediana Edad , Anciano de 80 o más Años , Ansiedad/terapia , Ansiedad/epidemiología , Psicoterapia/estadística & datos numéricos , Psicoterapia/métodos , Depresión/terapia , Depresión/epidemiología , Resultado del Tratamiento , Demencia Vascular/terapia , Demencia Vascular/psicología , Demencia Frontotemporal/terapia , Demencia Frontotemporal/psicología , Enfermedad de Alzheimer/terapiaRESUMEN
AIMS: We aimed to conduct a systematic literature review and meta-analysis to evaluate the efficacy of the original 14 session Cognitive Stimulation Therapy (CST) protocol in improving cognitive function and related outcomes in people with mild to moderate dementia. METHODS: Four databases were searched, up to May 2023, for randomized controlled trials of CST using the original protocol. Pre- and post-test means and measures of dispersion for intervention and control groups were extracted for each reported outcome and used to calculate effect sizes. Effect sizes were grouped by outcome and pooled in inverse variance weighted random effects models. RESULTS: Twelve studies were identified as meeting inclusion criteria. Of these, ten were given either a 'high' or 'medium' quality rating. The pooled results indicated that CST had a significant beneficial impact on global cognition, language, working memory, depression, neuropsychiatric symptoms, communication, self-reported quality of life and severity of dementia. CONCLUSIONS: CST as delivered in adherence to the original 14-session protocol is an efficacious treatment for mild to moderate dementia with improvements in cognition, affective symptoms and quality of life demonstrated from global trials.
Asunto(s)
Terapia Cognitivo-Conductual , Demencia , Ensayos Clínicos Controlados Aleatorios como Asunto , Humanos , Cognición/fisiología , Terapia Cognitivo-Conductual/métodos , Demencia/terapia , Demencia/psicología , Calidad de Vida , Ensayos Clínicos Controlados Aleatorios como Asunto/métodos , Resultado del TratamientoRESUMEN
Dementia is a global health concern with increasing numbers of people living long enough to develop dementia. People with dementia (PwD) may be particularly vulnerable to suicidality. However, suicide in PwD has not been thoroughly explored. The objective of this review was to determine the prevalence and risk factors of suicide in PwD. Five databases were searched from inception to July 2023. Peer-reviewed publications reporting prevalence, risk factors or quantitative summary data for suicide outcomes in PwD were included. Random effects models were used to calculate the pooled prevalence and effect sizes. 54 studies met inclusion criteria. In PwD, the point prevalence of suicidal ideation was 10â¯% (95â¯%CI=6â¯%;16â¯%), 2-year period prevalence of suicide attempts was 0.8â¯% (95â¯%CI=0.3â¯%;2â¯%), 10-year period prevalence of suicide attempts was 8.7â¯% (95â¯%CI=6.0â¯%%;12.7â¯%) and the incidence of death by suicide 0.1â¯% (95â¯%CI=0.1â¯%;0.2â¯%). Compared to not having dementia, a diagnosis of dementia increased risk of suicidal ideation (OR=1.62[95â¯%CI=1.17;2.24]) but not risk of suicide attempt (OR=1.77 [95â¯%CI=0.85;3.69]) or death by suicide (OR=1.30 [95â¯%CI=0.81;2.10]). People with moderate dementia had significantly increased risk of suicidal ideation than those with mild dementia (OR=1.59[95â¯%CI=1.11;2.28]), younger PwD were at increased risk of dying by suicide (OR=2.82[95â¯%CI=2.16;3.68]) and men with dementia were more likely to attempt (OR=1.28[95â¯%CI=1.25;1.31]) and die by suicide (OR=2.88[95â¯%CI=1.54;5.39]) than women with dementia. This review emphasises the need for mental health support and suicide prevention in dementia care, emphasising tailored approaches based on age, symptoms, and being male.